Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery
SPECKLETHO
1 other identifier
interventional
164
1 country
1
Brief Summary
In postoperative thoracic surgery (lobe resection, pneumonectomy or wedge resection), cardiovascular complications are the most frequent (10 to 15%) with a significant morbi-mortality rate. Right ventricular (RV) dysfunction is a complication that can be multifactorial in post thoracic surgery. The RV longitudinal shortening fraction (RV-LSF) is a new 2D-STE parameters able to more accurately detect patients with RV dysfunction compared to conventional echocardiographic parameters. This project is a single-center, prospective, interventional study of patients hospitalized at the Amiens University Hospital for scheduled thoracic surgery. TTE is performed preoperatively, at day 2 and day 15 following the thoracic surgery. Echocardiographic parameters will be measured by an echocardiographic expert in offline with a dedicated software. MACE criteria will be collected at day 2, day 15 and day-30 following the thoracic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2021
CompletedStudy Start
First participant enrolled
September 15, 2021
CompletedFirst Posted
Study publicly available on registry
September 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedFebruary 8, 2023
February 1, 2023
3 years
September 15, 2021
February 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
occurrence of a major cardiovascular event (MACE)
MACE is a composite criteria. MACES criteria is defined as the occurrence of at least one of the following events: A cardiovascular death or a documented supraventricular tachycardia (atrial fibrillation and/or flutter) of duration \> 30 seconds or, an acute myocardial infarction or, an hospitalization for a right ventricular failure or, an hospitalization for a left ventricular failure.
day 30
Secondary Outcomes (10)
Variation of RV systolic function from baseline in patients with MACE
at day 1
Variation of RV systolic function from baseline in patients without MACE
at day 1
Variation of RV systolic function from baseline in patients with MACE
at day 2
Variation of RV systolic function from baseline in patients without MACE
at day 2
Variation of RV systolic function from baseline in patients with MACE
at day 15
- +5 more secondary outcomes
Interventions
the included patients have a TTE preoperatively in order to evaluate the RV systolic function. TTE will also be done at day 2 and day-15 during the follow-up surgical consultation.
Eligibility Criteria
You may qualify if:
- Adult patient (\>18 years)
- Patient hospitalized at the Amiens University Hospital for scheduled thoracic surgery (lobectomy, pneumonectomy, wedge resection).
- Surgery by thoracotomy or video-assisted thoracic surgery
- Information of the patient and collection of his non-opposition
You may not qualify if:
- Patient with poor echogenicity on TTE not allowing evaluation of 2D-STE or conventional parameters of the RV.
- Patient with a rapid supraventricular rhythm disorder (HR \> 100) at the time of TTE
- Patient under mechanical ventilation
- Patient under extracorporeal membrane oxygenation
- Patients under guardianship or legal protection
- Patients whose clinical condition does not allow for their non-opposition
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens Picardie
Amiens, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2021
First Posted
September 29, 2021
Study Start
September 15, 2021
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
February 8, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share